Anti-integrin alphaVbeta6 antibody titer and the development of ulcerative colitis: a prospective cohort study in young pepole

Anti-integrin alphaVbeta6 antibody titer and the development of ulcerative colitis: a prospective cohort study - Anti-integrin alphaVbeta6 antibody titer and the development of ulcerative colitis: a prospective cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057572

Enrollment

120

Registered

2025-04-10

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who enroll in Kyorin University School of Medicine in 2024.

Exclusion criteria

Exclusion criteria: Subjects who do not consent to participate in the study.

Design outcomes

Primary

Measure	Time frame
Association between anti-integrin alphaVbeta6 antibody and the development of ulcerative colitis	—

Secondary

Measure	Time frame
Anti-integrin alphaVbeta6 antibody positive rate Association between anti-integrin alphaVbeta6 antibody and ulcerative colitis prevalence	—

Countries

Japan

Contacts

Public ContactJun Miyoshi

Kyorin University School of Medicine Department of Gastroenterology and Hepatology

jmiyoshi@ks.kyorin-u.ac.jp0422-47-5511

Outcome results